These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 8843288)
1. In vitro and in vivo activities of LB10522, a new catecholic cephalosporin. Kim MY; Oh JI; Paek KS; Kim YZ; Kim IC; Kwak JH Antimicrob Agents Chemother; 1996 Aug; 40(8):1825-31. PubMed ID: 8843288 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin. Nishino T; Otsuki M; Hatano K; Nishihara Y Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935 [TBL] [Abstract][Full Text] [Related]
3. In vitro antibacterial activities of FK037: a new parenteral cephalosporin. Inoue K; Inoue E; Mitsuhashi S Chemotherapy; 1995; 41(4):257-66. PubMed ID: 7555206 [TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of E1077, a new cephalosporin with a broad antibacterial spectrum. Watanabe N; Hiruma R; Katsu K Antimicrob Agents Chemother; 1992 Mar; 36(3):589-97. PubMed ID: 1622167 [TBL] [Abstract][Full Text] [Related]
5. The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents. Cheng AF; Ling TK; Lam AW; Fung KS; Wise R J Antimicrob Chemother; 1993 May; 31(5):699-709. PubMed ID: 8335498 [TBL] [Abstract][Full Text] [Related]
6. The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa. Neu HC; Chin NX; Labthavikul P Infection; 1985; 13(3):146-55. PubMed ID: 3928497 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity and beta-lactamase stability of GR69153, a new long-acting cephalosporin. Chin NX; Gu JW; Fang W; Neu HC Antimicrob Agents Chemother; 1991 Feb; 35(2):259-66. PubMed ID: 2024959 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of Ro 09-1428 compared to other cephalosporins. Chin NX; Gu JW; Fang W; Neu HC Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):669-75. PubMed ID: 1748124 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae. Klein O; Chin NX; Huang HB; Neu HC Antimicrob Agents Chemother; 1994 Dec; 38(12):2896-901. PubMed ID: 7695279 [TBL] [Abstract][Full Text] [Related]
11. In-vitro antibacterial activity of DQ-2556 and its stability to various beta-lactamases. Fujimoto T; Watanabe M; Inoue M; Mitsuhashi S J Antimicrob Chemother; 1990 Sep; 26(3):329-41. PubMed ID: 2228824 [TBL] [Abstract][Full Text] [Related]
13. In-vitro and in-vivo antibacterial activity of LB10517, a novel catechol-substituted cephalosporin with a broad antibacterial spectrum. Song HK; Oh JI; Kim MY; Kim YZ; Kim IC; Kwak JH J Antimicrob Chemother; 1996 Apr; 37(4):711-26. PubMed ID: 8722537 [TBL] [Abstract][Full Text] [Related]
14. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Jones RN; Sader HS; Fritsche TR; Pottumarthy S Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity and beta-lactamase stability of LJC 10,627. Neu HC; Gu JW; Fang W; Chin NX Antimicrob Agents Chemother; 1992 Jul; 36(7):1418-23. PubMed ID: 1510436 [TBL] [Abstract][Full Text] [Related]
16. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus. Jones ME Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin. Pillar CM; Aranza MK; Shah D; Sahm DF J Antimicrob Chemother; 2008 Mar; 61(3):595-602. PubMed ID: 18218646 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group. Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863 [TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of ceftazidime, a beta-lactamase stable cephalosporin. Neu HC J Antimicrob Chemother; 1981 Sep; 8 Suppl B():131-4. PubMed ID: 19810175 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome. Mitsukude M; Inoue M; Mitsuhashi S Arzneimittelforschung; 1989 Jan; 39(1):26-30. PubMed ID: 2785801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]